Vivek Podder

9PUBLICATIONS
33CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyCardiology (incl. cardiovascular diseases)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Brian M Slomovitz, S John Weroha, Wei Deng

|Dec 02, 2025
Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities.

Vivek Podder, Robert L Coleman, Andrea R Hagemann

|Dec 17, 2024
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review.

Vivek Podder, Tulika Ranjan, Kim Margolin

|Oct 16, 2024
Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions.

Tulika Ranjan, Vivek Podder, Kim Margolin

|Feb 09, 2021
Willingness to work during initial lockdown due to COVID-19 pandemic: Study based on an online survey among physicians of Bangladesh.

Md Abdur Rafi, M Tasdik Hasan, Dewan Tasnia Azad

|Dec 17, 2020
Prevalence of anxiety and depressive symptoms among physicians during the COVID-19 pandemic in Bangladesh: a cross-sectional study.

M Tasdik Hasan, Sahadat Hossain, Farhana Safa

Pageof 2

Frequent Collaborators

2 joint publications

Robert L Coleman

2 joint publications

Brian M Slomovitz

2 joint publications

Manmeet Singh Ahluwalia

2 joint publications

Md Abdur Rafi